Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors

CHEN, D.-F ; PRASAD, V. K ; LONG, G. D ; YANG, Y ; CHAO, N. J ; RIZZIERI, D. A ; BROADWATER, G ; REINSMOEN, N. L ; DEOLIVEIRA, A ; CLARK, A ; SULLIVAN, K. M ; CHUTE, J. P ; HORWITZ, M. E ; GASPARETTO, C

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.817-823 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível